Mentice

Mentice is a medical device company founded in 1999 that specializes in advanced software and hardware simulation solutions for image-guided interventional therapies, particularly in endovascular procedures. The company develops products that help healthcare professionals enhance their procedural skills in neurovascular, cardiovascular, and peripheral interventions, ultimately improving clinical outcomes and productivity. Mentice’s simulators are scientifically validated and tailored for healthcare providers and the medical device industry. The company offers a variety of simulation solutions, including the VIST® Case-It technology, which enables the creation of patient-specific endovascular simulation cases. This technology supports clinicians in preparing for complex interventions by allowing them to rehearse procedures with individualized training cases. Mentice’s tools are widely used in medical education and certification, adapting to the needs of evolving clinical curricula. Mentice holds around 50 medical simulation patents covering over 30 different training procedures. Its customers include hospitals and medical professionals involved in minimally invasive interventional procedures, as well as medical device manufacturers focused on improving clinical performance through simulation-based training. Mentice is publicly traded on the Nasdaq First North Growth Market under the ticker MNTC.

• Employees 140
• Founded 1998
• Annual Revenue $26424000
• Total Funding $277350